Article Text
Abstract
Objectives: To investigate whether axonal damage in primary progressive (PP) multiple sclerosis (MS), as measured by proton magnetic resonance spectroscopy (HMRS) imaging and brain atrophy, is a function of T2 weighted brain lesion volume.
Methods: 34 PP MS patients were divided into two categories: low (<3 cm3, n = 18) or high (≥3 cm3, n = 16) T2 lesion load (LL). An Index of Brain Atrophy (IBA) was calculated and HMRS metabolite ratios were derived from a central brain area centred at the corpus callosum.
Results: Patient groups did not differ with regard to clinical characteristics and showed lower mean IBA and mean N-acetylaspartate:creatinine (NAA:Cr) ratios compared to healthy controls.
Conclusion: PP patients with low and high brain T2LL have detectable brain atrophy and NAA:Cr reduction compared to healthy controls. In PP MS, T2 lesions alone are insufficient to explain the presence of brain atrophy and decrease in NAA:Cr.
- N-acetylaspartate
- proton nuclear magnetic resonance spectroscopy
- brain atrophy
- primary progressive multiple sclerosis
- CB, central brain
- COV, coefficient of variation
- Cr, creatinine
- CSG, cerebrospinal fluid
- EDSS, Expanded Disability Status Score
- HMRS, proton magnetic resonance spectroscopy
- IBA, Index of Brain Atrophy
- LL, lesion load
- MRI, magnetic resonance imaging
- MS, multiple sclerosis
- NAA, N-acetylaspartate
- NAWM, normal appearing white matter
- PD, proton density
- PP, primary progressive
- ROI, region of interest
- RR, relapse remitting
- SP, secondary progressive
Statistics from Altmetric.com
- N-acetylaspartate
- proton nuclear magnetic resonance spectroscopy
- brain atrophy
- primary progressive multiple sclerosis
- CB, central brain
- COV, coefficient of variation
- Cr, creatinine
- CSG, cerebrospinal fluid
- EDSS, Expanded Disability Status Score
- HMRS, proton magnetic resonance spectroscopy
- IBA, Index of Brain Atrophy
- LL, lesion load
- MRI, magnetic resonance imaging
- MS, multiple sclerosis
- NAA, N-acetylaspartate
- NAWM, normal appearing white matter
- PD, proton density
- PP, primary progressive
- ROI, region of interest
- RR, relapse remitting
- SP, secondary progressive
Footnotes
-
Competing interests: DE Goodkin was an employee of Immunex Corporation at the time of submission of this manuscript